Evaluation of Non Traditional Cardiovascular Risk Factors in Chronic Kidney Disease Patients Starting Dialysis

University Hospital, Montpellier5 sites in 1 country400 target enrollmentDecember 8, 2011

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Kidney Disease
Sponsor: University Hospital, Montpellier
Enrollment: 400
Locations: 5
Primary Endpoint: Progression of vascular calcifications during a 2 year follow up according to plasma osteoprotegerin level at inclusion
Status: Recruiting
Last Updated: 4 years ago

To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up

Registry

clinicaltrials.gov

Start Date

December 8, 2011

End Date

February 2027

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Sponsor

Responsible Party

Sponsor

Progression of vascular calcifications during a 2 year follow up according to plasma osteoprotegerin level at inclusion

Time Frame: 2 years after inclusion

osteoprotegerin will be measured in picomol/L; vascular calcifications will be measured at inclusion and after the 2 year follow up

Occurence of cardiovascular events during a 2 year follow up(2 years after inclusion)
Progression of vascular calcifications during a 2 year follow up according to plasma fibroblast growth factor 23 level at inclusion(2 years after inclusion)